Search

Geron Corp

Cerrado

SectorSanidad

1.46 -4.58

Resumen

Variación precio

24h

Actual

Mínimo

1.44

Máximo

1.53

Métricas clave

By Trading Economics

Ingresos

-13M

-17M

Ventas

5.6M

57M

BPA

-0.02

Margen de beneficios

-29.019

Empleados

258

EBITDA

-16M

-12M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+181.17% upside

Dividendos

By Acuity

Próximas Ganancias

4 nov 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

128M

949M

Apertura anterior

6.04

Cierre anterior

1.46

Noticias sobre sentimiento de mercado

By Acuity

67%

33%

303 / 340 Clasificación en Healthcare

Geron Corp Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

13 ago 2026, 23:36 UTC

Shares of Geron Corp are trading higher in after-market hours, reflecting a strong performance backdrop despite no specific news identified.

12 ago 2026, 23:36 UTC

Geron Corp shares are higher in after-market trading, reflecting an upward move since Wednesday's close. The stock remains above its 20-day moving average.

11 ago 2026, 22:52 UTC

Geron Corp shares are lower in after-market trading with no specific news identified. Broader market sentiment was pressured by rising crude oil prices.

10 ago 2026, 23:06 UTC

Geron Corp shares are higher in after-market hours, reflecting a gain despite mixed market sentiment and geopolitical tensions affecting global energy markets.

7 ago 2026, 20:03 UTC

Geron Corp shares are sharply lower during Friday's trading session, reflecting a broader market decline with no specific news identified to explain the movement.

6 ago 2026, 23:06 UTC

Geron Corp shares traded roughly flat in after-market hours, remaining unchanged since Thursday's close amid a strong recent performance backdrop.

5 ago 2026, 23:31 UTC

Geron Corp shares are lower in after-market hours, continuing a decline that began during regular trading, with no specific news identified.

4 ago 2026, 23:36 UTC

Geron Corp shares are lower in after-market trading, nearing the bottom of their one-month range and below the 20-day moving average.

3 ago 2026, 23:06 UTC

Geron Corp shares are lower in after-market hours, continuing a steady decline since Monday's close and remaining below the 20-day moving average.

31 jul 2026, 20:02 UTC

Geron Corp shares are lower as the Biotechnology sub-sector declines. The stock pulled back from an earlier session high, finishing below its 20-day moving average.

30 jul 2026, 20:56 UTC

Geron Corp shares are higher in after-market hours, influenced by positive corporate earnings amid broader market uncertainty following the Federal Reserve's interest rate decision.

29 jul 2026, 19:32 UTC

Macro Event

Geron Corp shares are lower as market volatility rises following the Federal Reserve's interest rate decision amid ongoing economic growth and inflation concerns.

28 jul 2026, 18:51 UTC

Shares of Geron Corp are lower today amid broader market volatility and uncertainty regarding Federal Reserve decisions. The stock declined since Monday's close.

27 jul 2026, 23:16 UTC

Geron Corp shares are lower in after-market trading, despite earlier gains, with no specific company news driving the decline.

24 jul 2026, 19:46 UTC

Geron Corp shares are lower in Friday's session amid broader market volatility and uncertainty from fluctuating oil prices and new U.S. tariffs.

23 jul 2026, 10:11 UTC

Shares of Geron Corp are higher in pre-market hours, trading above their 20-day moving average. No specific company news was identified.

22 jul 2026, 18:51 UTC

Geron Corp shares are lower today amid broader market trends, as crude oil prices surge due to geopolitical tensions.

21 jul 2026, 23:41 UTC

Geron Corp shares are lower in after-market trading, declining to their lowest point since Tuesday's close. No specific news was identified to explain the drop.

20 jul 2026, 23:56 UTC

Geron Corp shares are lower in after-market hours, continuing a decline since Monday's close amid broader market uncertainties and a drop in the leading economic index.

Comparación entre iguales

Cambio de precio

Geron Corp previsión

Precio Objetivo

By TipRanks

181.17% repunte

Estimación a 12 Meses

Media 4.33 USD  181.17%

Máximo 6 USD

Mínimo 3 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Geron Corp Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

4 ratings

3

Comprar

1

Mantener

0

Vender

Sentimiento

By Acuity

303 / 340 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura bajista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Geron Corp

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in myeloid hematologic malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.
help-icon Live chat